Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allmed SolutionsXTAE:ALMD 30 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates XTAE:ALMD with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Allmed Solutions ranks worse than 122699.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Allmed Solutions's EBITDA for the
six
months ended in Dec. 2025 was ₪-8.37 Mil. Allmed Solutions's Revenue for the
six
months ended in Dec. 2025 was ₪0.00 Mil. Therefore, Allmed Solutions's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Allmed Solutions EBITDA Margin % Related Terms
Allmed Solutions EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Allmed Solutions's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ALMD vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Allmed Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allmed Solutions EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Allmed Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Allmed Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allmed Solutions (XTAE:ALMD) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Allmed Solutions and its competitors. According to the industry distribution chart, Allmed Solutions ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Allmed Solutions' EBITDA Margin % too high?
Allmed Solutions' current EBITDA Margin % is 0.00%. Based on the distribution chart, Allmed Solutions ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Allmed Solutions has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Allmed Solutions' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Allmed Solutions ranks #999999 out of 815 companies for EBITDA Margin %. This places Allmed Solutions in the lower half of its industry. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Allmed Solutions and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allmed Solutions's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allmed Solutions stock overvalued right now?
Allmed Solutions (XTAE:ALMD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Allmed Solutions' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Allmed Solutions (XTAE:ALMD), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ALMD has been successfully added to your 
